<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549909</url>
  </required_header>
  <id_info>
    <org_study_id>1902-VGO-019-EM</org_study_id>
    <nct_id>NCT04549909</nct_id>
  </id_info>
  <brief_title>Biochemical Pregnancy Loss. A Multicenter Retrospective Study</brief_title>
  <acronym>BPL</acronym>
  <official_title>Is Biochemical Pregnancy Loss Associated to Embryo or Endometrium? A Multicenter Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Vigo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IVI Madrid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación IVI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IVI Vigo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biochemical pregnancy loss (BPL) is a very frequent issue in human reproduction. After the&#xD;
      implantation of the embryo, hCG disappears very soon from the maternal bloodstream and no&#xD;
      evidence of a clinical pregnancy is seen. Different studies showed that factors such as age,&#xD;
      oocyte and embryo quality, and endometrium receptivity may have something to do with the&#xD;
      occurrence of biochemical pregnancy loss post assisted reproduction treatment.&#xD;
&#xD;
      The main aim of this study is to evaluate the incidence of biochemical pregnancy loss (BPL)&#xD;
      in three different cohort populations; patients undergoing frozen embryo transfer (FET) from&#xD;
      own oocytes after preimplantation genetic testing for aneuploidy (PGT-A), patients undergoing&#xD;
      FET from own and donated oocytes and with endometrial receptivity array (ERA), and patients&#xD;
      undergoing FET from own or donated oocytes (without PGTA or ERA test).&#xD;
&#xD;
      We will analyse the incidence of BPL in these populations and try to determine the role of&#xD;
      the euploid status embryo in the first group, the endometrium in the second group and the&#xD;
      third one as control group. We are waiting to find the value of both players in the origin of&#xD;
      BPL.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Human embryo implantation is a poorly understood process. Once the embryo implants in the&#xD;
      endometrium, it starts to secrete hCG that can be measured in the maternal blood as early as&#xD;
      9 days after implantation. Only a minimal number of pregnancies get to newborn, and the&#xD;
      majority are lost before reach the first trimester (Larsen et al., 2013).&#xD;
&#xD;
      We are looking for the role of the embryo after controlling its chromosomal ploidy, and the&#xD;
      endometrium after controlling its transcriptomic expression. We will also use a no exposed&#xD;
      group to the controlled euploid embryo factor neither endometrial factor that is the oocyte&#xD;
      donation group. This analysis expects to provide more information about the key role of&#xD;
      embryo or endometrium in BPL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2019</start_date>
  <completion_date type="Actual">January 15, 2020</completion_date>
  <primary_completion_date type="Actual">January 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemical pregnancy loss (BPL)</measure>
    <time_frame>Since 2013 to april 2019</time_frame>
    <description>when the maternal serum levels of β-hCG are higher than 10 UI/L, but in the transvaginal ultrasound is not possible to appreciate any gestational structure (dichotomous qualitative variable: yes/no). This variable is considered as the fraction between patients whose β-hCG is higher than 10 UI/L, without clinically recognized pregnancy, by number of pregnant patients.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">20000</enrollment>
  <condition>Pregnancy Loss, Early</condition>
  <arm_group>
    <arm_group_label>preimplantation genetic testing for aneuploidy (PGT-A) Group</arm_group_label>
    <description>Patients who have undergone preimplantation genetic testing for aneuploidy (PGT-A) (transfer of own frozen embryo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endometrial receptivity array (ERA) Group</arm_group_label>
    <description>Patients who have undergone frozen embryo transfer (FET) with endometrial receptivity array (ERA) test (embryos from own or donated oocytes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL OWN (CO) Group</arm_group_label>
    <description>Control group of FET from own oocytes (without ERA or PGT-A)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL DONATED(CD) Group</arm_group_label>
    <description>Control group of FET from donated oocytes (without ERA or PGT-A)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collect retrospectively data</intervention_name>
    <description>Analyse the incidence of BPL in these populations</description>
    <arm_group_label>CONTROL DONATED(CD) Group</arm_group_label>
    <arm_group_label>CONTROL OWN (CO) Group</arm_group_label>
    <arm_group_label>endometrial receptivity array (ERA) Group</arm_group_label>
    <arm_group_label>preimplantation genetic testing for aneuploidy (PGT-A) Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infertile patients who come to participating centres for assisted reproduction treatments.&#xD;
        Patients will be divided into 4 groups according to the treatment carried out: PGT-A, ERA,&#xD;
        FET from own oocytes (CO) or FET from donated oocytes (CD).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with the following selection criteria:&#xD;
&#xD;
          -  IVF/ICSI patients aged between 18 and 44&#xD;
&#xD;
          -  BMI 18-30 kg/m2&#xD;
&#xD;
          -  Frozen embryo transfer from own oocytes after PGT-A&#xD;
&#xD;
          -  Frozen embryo transfer with ERA test (from own or donated oocytes)&#xD;
&#xD;
          -  Frozen embryo transfer (from own or donated oocytes)&#xD;
&#xD;
          -  Single embryo transfer (SET) in all cycles&#xD;
&#xD;
          -  Patients without uterine malformations&#xD;
&#xD;
          -  Patients without recurrent miscarriage (≥ 3)&#xD;
&#xD;
          -  Patients with adequate endometrial thickness (&gt; 7mm)&#xD;
&#xD;
          -  Patients without thyroid autoimmunity&#xD;
&#xD;
          -  Patients without thrombophilia&#xD;
&#xD;
          -  Exclude cycles with exclusively PGT-M&#xD;
&#xD;
          -  Exclude FET in ovarian stimulated cycles&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclude cycles with exclusively PGT-M Exclude FET in ovarian stimulated cycles&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elkin DR Muñoz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Vigo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI Vigo</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, Simón C. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011 Jan;95(1):50-60, 60.e1-15. doi: 10.1016/j.fertnstert.2010.04.063. Epub 2010 Jul 8.</citation>
    <PMID>20619403</PMID>
  </results_reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 21, 2020</last_update_submitted>
  <last_update_submitted_qc>September 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>abortion</keyword>
  <keyword>bioquemical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Fetal Death</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

